RUA Life Sciences (GB:RUA)
LSE:RUA
Holding GB:RUA?
Track your performance easily

RUA Life Sciences (RUA) Financial Statements

2 Followers

RUA Life Sciences Financial Overview

RUA Life Sciences's market cap is currently ―. The company's EPS TTM is p-0.052; its P/E ratio is -2.29; RUA Life Sciences is scheduled to report earnings on July 22, 2025, and the estimated EPS forecast is p―. See an overview of income statement, balance sheet, and cash flow financials.
Sep 22Mar 22Sep 21Mar 21Sep 20
Income Statement-
Total Revenue-----
Gross Profit-----
EBIT-----
EBITDA-----
Net Income Common Stockholders-----
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments£ 2.51M£ 2.96M£ 4.76M£ 6.29M£ 1.01M
Total Assets£ 6.60M£ 7.63M£ 8.88M£ 10.15M£ 4.04M
Total Debt£ 454.00K£ 344.00K£ 378.00K£ 410.00K£ 308.00K
Net Debt£ -2.06M£ -2.62M£ -4.38M£ -5.88M£ -701.00K
Total Liabilities£ 1.11M£ 1.04M£ 1.62M£ 1.65M£ 1.30M
Stockholders Equity£ 5.49M£ 6.58M£ 7.26M£ 8.51M£ 2.75M
Cash Flow-
Free Cash Flow-----
Operating Cash Flow-----
Investing Cash Flow-----
Financing Cash Flow-----
Currency in GBP

RUA Life Sciences Earnings and Revenue History

RUA Life Sciences Debt to Assets

RUA Life Sciences Cash Flow

RUA Life Sciences Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis